B-cell activity in children with malaria.

Area of Science:

• Immunology
• Hematology
• Infectious Diseases

Background:

• Red blood cell (RBC) complement regulatory proteins (CR1 and CD55) deficiency is linked to malarial anemia.
• This study investigates the role of B cell CD21, which shares functional similarities with RBC CR1, in malaria.

Purpose of the Study:

• To explore the involvement of B cell CD21 in the pathophysiology of severe malaria anemia (SMA).
• To compare B cell characteristics, including CD21 expression and complement deposition, between children with SMA and uncomplicated malaria (UM).

Main Methods:

• Case-control study in Kenya involving children with SMA and UM.
• Flow cytometry assessed B cell numbers (CD20+), CD21 expression, and C3dg deposition.
• ELISA measured soluble CD21 (sCD21) levels.
• Paired t tests were used for statistical analysis.

Main Results:

• Children with SMA exhibited higher lymphocyte counts and a greater number/percentage of activated B cells (CD20+).
• SMA patients showed significantly lower median fluorescence intensity of membrane-bound CD21 and increased C3dg deposition on B cells.
• Soluble CD21 levels were unexpectedly lower in SMA patients, suggesting CD21 shedding without release into circulation.

Conclusions:

• B cell involvement, characterized by increased proliferation, complement deposition, and loss of membrane-bound CD21, is implicated in severe malaria pathophysiology.
• The observed loss of CD21 on B cells in SMA is likely mediated by complement and does not follow classical enzymatic cleavage pathways.